Gwen Melincoff, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 7.50K shares in Protalix (Ticker: PLX), holds 52.47K shares in Collegium Pharmaceutical (Ticker: COLL). Most recently, Gwen Melincoff ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Gwen Melincoff latest transaction was an Uninformative Buy of ―.
What was Gwen Melincoff's most profitable transaction?
Gwen Melincoff’s most profitable transaction was an Informative Buy of SLNO stock on November 20, 2019. The return on the trade was 29.20%.
What is Gwen Melincoff's role in Tobira Therapeutics?
Gwen Melincoff's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.